Literature DB >> 3315232

Activated N-ras controls the transformed phenotype of HT1080 human fibrosarcoma cells.

H Paterson1, B Reeves, R Brown, A Hall, M Furth, J Bos, P Jones, C Marshall.   

Abstract

To investigate whether the activated N-ras oncogene of HT1080 human fibrosarcoma cells contributes to the expression of the transformed phenotype, we have isolated flat revertants. In two independent revertant lines, an increase in chromosomal ploidy occurred without a concomitant increase in the number of copies of the N-ras transforming allele. Immunoprecipitation confirms that the level of the mutant N-ras p21 gene product in the revertants is correspondingly lower than in HT1080. Analysis of sporadic tumors derived from the revertant cells reveals an increased dosage of the transforming allele. The revertants also retransform after transfection of cloned activated ras oncogenes. These results imply direct participation of an N-ras oncogene in maintaining the transformed phenotype of a human tumor cell line.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3315232     DOI: 10.1016/0092-8674(87)90103-6

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  34 in total

1.  Acutely transforming retrovirus expressing Nras generated from HT-1080 fibrosarcoma cells infected with the human retrovirus XMRV.

Authors:  Michael J Metzger; A Dusty Miller
Journal:  J Virol       Date:  2010-05-26       Impact factor: 5.103

2.  Malignant transformation of human fibroblasts caused by expression of a transfected T24 HRAS oncogene.

Authors:  P J Hurlin; V M Maher; J J McCormick
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

3.  Critical regulation of genes for tumor cell migration by AP-1.

Authors:  El Mustapha Bahassi; Saikumar Karyala; Craig R Tomlinson; Maureen A Sartor; Mario Medvedovic; Robert F Hennigan
Journal:  Clin Exp Metastasis       Date:  2004       Impact factor: 5.150

4.  Mutant p53 tumor suppressor alleles release ras-induced cell cycle growth arrest.

Authors:  G G Hicks; S E Egan; A H Greenberg; M Mowat
Journal:  Mol Cell Biol       Date:  1991-03       Impact factor: 4.272

5.  U1 small nuclear RNAs with altered specificity can be stably expressed in mammalian cells and promote permanent changes in pre-mRNA splicing.

Authors:  J B Cohen; S D Broz; A D Levinson
Journal:  Mol Cell Biol       Date:  1993-05       Impact factor: 4.272

6.  Loss of oncogenic ras expression does not correlate with loss of tumorigenicity in human cells.

Authors:  R Plattner; M J Anderson; K Y Sato; C L Fasching; C J Der; E J Stanbridge
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-25       Impact factor: 11.205

7.  A splicing enhancer in the 3'-terminal c-H-ras exon influences mRNA abundance and transforming activity.

Authors:  D Y Hwang; J B Cohen
Journal:  J Virol       Date:  1997-09       Impact factor: 5.103

8.  The normal human H-ras1 gene can act as an onco-suppressor.

Authors:  A Spandidos; N M Wilkie
Journal:  Br J Cancer Suppl       Date:  1988-12

9.  Transforming mutations of RAC guanosine triphosphatases in human cancers.

Authors:  Masahito Kawazu; Toshihide Ueno; Kenji Kontani; Yoshitaka Ogita; Mizuo Ando; Kazutaka Fukumura; Azusa Yamato; Manabu Soda; Kengo Takeuchi; Yoshio Miki; Hiroyuki Yamaguchi; Takahiko Yasuda; Tomoki Naoe; Yoshihiro Yamashita; Toshiaki Katada; Young Lim Choi; Hiroyuki Mano
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-04       Impact factor: 11.205

10.  Tumor suppression involves down-regulation of interleukin 3 expression in hybrids between autocrine mastocytoma and interleukin 3-dependent parental mast cells.

Authors:  I D Diamantis; A P Nair; H H Hirsch; C Moroni
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.